Brief: Niagen Bioscience Confirms Its Operations Remain Resilient Amid New Tariff Developments
07/04/2025 14:09
April 7 (Reuters) - Niagen Bioscience Inc NAGE.O: NIAGEN BIOSCIENCE CONFIRMS ITS OPERATIONS REMAIN RESILIENT AMID NEW TARIFF DEVELOPMENTS Source text: ID:nBw36hbPva Further company coverage: NAGE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Niagen Bioscience
See all newsAs weight-loss drug users turn to dietary supplements, doctors, regulators raise flags
Niagen Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Niagen Bioscience Q2 net sales fall, missing estimates
Niagen Bioscience Inc expected to post earnings of 2 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce